KemPharm's (KMPH) KP511 Receives FDA Fast-Track Designation
Tweet Send to a Friend
KemPharm, Inc. (Nasdaq: KMPH) announced that KP511, KemPharm’s prodrug of hydromorphone, has been granted “Fast Track” designation by the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
